Group companies

KeriMedical:
Market leader in thumb arthritis treatment

KeriMedical SA is a Geneva-based medical device company specialising in implants and prostheses for hand and wrist surgery, with a particular focus on the treatment of thumb arthritis. Founded in 2016 by Bernard Prandi and Dougal Bendjaballah, the company was established to address a gap in innovation and surgical education in hand surgery — an area historically underserved by larger orthopaedic manufacturers. Its portfolio targets rhizarthrosis, a condition affecting a significant proportion of the population over 40, offering total joint arthroplasty solutions that preserve joint anatomy and function compared to traditional surgical approaches. Surgeon training is central to KeriMedical's strategy, with its KeriAcademy facility in Archamps, France, having trained more than 600 surgeons since 2017. The company operates two production facilities in France, supporting research and development, manufacturing, logistics, and training under an integrated model. With average annual sales growth of 30% in recent years and considerable market expansion potential across Europe, KeriMedical is a well-positioned, high-growth specialist in upper extremity surgery.

NeoOrtho:
Making surgical solutions more accessible

NeoOrtho (NeoOrtho Produtos Ortopédicos S.A.) is a Brazilian manufacturer of orthopaedic implants and surgical solutions, headquartered in Curitiba, Paraná, and specialising in trauma, craniomaxillofacial, spinal, and customised prosthetic devices. Founded in 2004 as a spin-off from Neodent, a dental implant company established by Dr Geninho Thomé, NeoOrtho has grown into an independent brand with a portfolio of more than 14,000 SKUs and a dedicated manufacturing facility. The company's core focus is on making reliable surgical solutions accessible to a broader population through competitive pricing, with approximately 75% of the Brazilian orthopaedic market served through public hospital tenders. NeoOrtho's local production footprint provides a strategic advantage for expansion across the Mercosul trade bloc, and the company currently serves markets in Brazil, Mexico, Ecuador, Argentina, Colombia, and Guatemala. On 17 March 2025, Medartis Holding AG acquired a 51% controlling stake in NeoOrtho, with a clear pathway to reach 100% ownership by 2028/29. Under a dual-brand strategy, both companies will continue to operate independently, with NeoOrtho's value-segment positioning complementing Medartis' premium-focused portfolio across key growth markets.

CADskills:
Advancing patient-specific implants and titanium 3D printing

CADskills is a Belgium-based specialist in patient-specific implant solutions and titanium 3D printing, operating across extremity and craniomaxillofacial surgery. Founded by Prof. Dr mult. Maurice Mommaerts, whose research in personalised implant design and additive manufacturing has contributed to advancing the field, the company holds certification to manufacture class III medical devices – the highest regulatory classification for implants. Its highly integrated model covers design, manufacturing, and packaging, and its titanium printing capabilities are transferable to other regions, supporting broader geographic expansion. CADskills' portfolio spans temporomandibular joint replacement, subperiosteal implants for patients with significant bone loss, and facial contouring solutions, as well as carpal bone arthroplasties through the Carpitech™ family, further strengthening Medartis' position in small bone replacement of the hand. In May 2026, Medartis acquired CADskills, reinforcing its strategic focus on complex clinical applications in extremity and head surgery. Following the integration, Prof. Dr Mommaerts will continue to provide scientific and clinical expertise to support the expansion phase.